Clinico-etiological study with response to specific treatment in childhood urticaria

Surender Pal Gupta1, Nidhi Jindal, Sanjeev Gupta

  • 1Department of Pediatrics, MM Institute of Medical Sciences and Research, Mullana, Ambala, India.

Insights

Infections are the most common cause of childhood urticaria, including acute and chronic forms. This study investigated etiological factors and treatment responses in pediatric patients with this common skin condition.

Area of Science:

  • Pediatric Dermatology
  • Immunology

Background:

  • Urticaria is a frequent dermatological issue in adults, but chronic urticaria (CU) is less common in children.
  • Limited data exists on pediatric urticaria etiology, necessitating further research.

Purpose of the Study:

  • To identify etiological factors contributing to urticaria in pediatric patients.
  • To assess treatment responses in children diagnosed with urticaria.

Main Methods:

  • Retrospective analysis of 80 pediatric patients (ages 1-14) with urticaria.
  • Evaluation included detailed history, physical examination, laboratory investigations, and specific in vivo/in vitro tests.

Main Results:

  • Infection was the most frequent underlying cause of urticaria in children.
  • Thyroid dysfunction was noted in 12 patients; 2 had positive thyroid anti-peroxidase antibodies.
  • Autologous serum skin test was positive in 17 patients.

Conclusions:

  • Infections represent the primary etiological factor for pediatric urticaria.
  • Further research is needed to fully understand the diverse causes of urticaria in children.
Abstract

Related Concept Videos

Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...